Canonical: https://ownershiptrace.com/13f/companies/206

# Who owns Revolution Medicines, Inc. (RVM)? Elite investor 13F holders

8 tracked elite investors reported holding Revolution Medicines, Inc as of 2026-06-30, including Alphabet, Caligan Partners, D.E. Shaw, Gotham Asset Management, Tudor Investment. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

8 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS…

## Reported holders and securities, including exits (up to 20)

| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|  --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| [Alphabet](https://ownershiptrace.com/13f/investors/86) | REVOLUTION MEDICINES INC | SHARE | 2026-06-30 | 2026-08-07 00:00:00 | 551842806.00 USD | 2946619.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1652044/0001652044-26-000073-index.html) |
| [Caligan Partners](https://ownershiptrace.com/13f/investors/125) | REVOLUTION MEDICINES INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 367404968.00 USD | 1961795.000000 | Shares | add | [Original filing](https://www.sec.gov/Archives/edgar/data/1727492/0001420506-26-001809-index.html) |
| [D.E. Shaw](https://ownershiptrace.com/13f/investors/98) | REVOLUTION MEDICINES INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 2322272.00 USD | 12400.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1009207/0001104659-26-097217-index.html) |
| [Duquesne Family Office](https://ownershiptrace.com/13f/investors/30) | REVOLUTION MEDICINES INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | [Original filing](https://www.sec.gov/Archives/edgar/data/1536411/0001536411-26-000006-index.html) |
| [Gotham Asset Management](https://ownershiptrace.com/13f/investors/94672) | REVOLUTION MEDICINES INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 22605071.00 USD | 120702.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1510387/0001398344-26-014644-index.html) |
| [D.E. Shaw](https://ownershiptrace.com/13f/investors/98) | REVOLUTION MEDICINES INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 14855243.00 USD | 1580345.000000 | Shares | hold | [Original filing](https://www.sec.gov/Archives/edgar/data/1009207/0001104659-26-097217-index.html) |
| [Tudor Investment](https://ownershiptrace.com/13f/investors/94675) | REVOLUTION MEDICINES INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 2996480.00 USD | 16000.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/923093/0000902664-26-003485-index.html) |
| [Anson Funds](https://ownershiptrace.com/13f/investors/117) | REVOLUTION MEDICINES INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 3745600.00 USD | 20000.000000 | Shares | — | [Original filing](https://www.sec.gov/Archives/edgar/data/1491072/0001193125-26-349150-index.html) |
| [Oaktree Capital Management](https://ownershiptrace.com/13f/investors/44) | REVOLUTION MEDICINES INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 1442773.00 USD | 1150000.000000 | Principal | buy | [Original filing](https://www.sec.gov/Archives/edgar/data/949509/0000949509-26-000005-index.html) |
| [Renaissance Technologies LLC](https://ownershiptrace.com/13f/investors/63) | REVOLUTION MEDICINES INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | [Original filing](https://www.sec.gov/Archives/edgar/data/1037389/0001037389-26-000059-index.html) |
| [Ancora Advisors / Ancora Holdings](https://ownershiptrace.com/13f/investors/101) | REVOLUTION MEDICINES INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 3746.00 USD | 20.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1446114/0001446114-26-000012-index.html) |

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

[How to read the data](https://ownershiptrace.com/docs#reading-the-data) · [Disclaimer](https://ownershiptrace.com/disclaimer)